Frontlight ResearchEarly access
Trial site
Instituto de Oncologia Saint Gallen
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 34 trials
- Phase 2/33 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Bristol-Myers Squibb3 trials
- Eli Lilly and Company2 trials
- Mirati Therapeutics Inc.1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Active, not recruiting
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026